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The matrix protein of influenza virus is a major structural component of the virion which is generally believed to bridge
between the membrane envelope and the ribonucleocapsid core. To investigate the interaction of M1 with cellular mem-
branes in the absence of other influenza proteins, we examined its distribution by subcellular fractionation after expression
in HeLa cells. Approximately 81 to 88% of M1 protein, expressed without other viral proteins, was soluble, whereas the
remaining 12 to 19% was tightly associated with membranes. Conditions known to release peripherally associated membrane
proteins did not detach M1 proteins from isolated membranes, suggesting that the fraction of M1 bound to membranes
behaves as an integral protein. Coexpression of M1 with hemagglutinin or neuraminidase did not alter the extent of
membrane association of M1 protein, indicating that there is no strong interaction between M1 and the cytoplasmic tails
of the viral glycoproteins. Additional attempts were made to identify membrane binding domains in M1 protein. Mutants
constructed with mutations in the four hydrophobic regions thought to be responsible for membrane association still
exhibited the same levels of membrane association as that observed with wild-type matrix protein. Therefore, specific
hydrophobic domains are apparently not required for membrane binding. q 1996 Academic Press, Inc.
INTRODUCTION bilayer surrounding an inner nucleocapsid core. The vi-
ruses acquire their lipid bilayer as they bud from the
The assembly of components of enveloped viruses host cell plasma membrane at areas enriched in viral
at the plasma membrane and their budding from the envelope proteins. In the case of influenza A viruses
membrane have not been defined at the molecular level there are four different viral membrane proteins: the hem-
of protein–protein interactions. It has been suggested agglutinin (HA) protein which recognizes neuraminic acid
that there are specific interactions involving viral tails containing receptors at the cell surface; the enzyme neur-
and the nucleocapsid which together assist the formation aminidase (NA) which destroys cellular receptors; a
of a budding virion (reviewed in Compans and Choppin, small transmembrane protein, M2; and the most abun-
1975, and Dubois-Dalcq et al., 1984). With the alpha virus dant viral protein, M1. In the infected cell, M1 is produced
Sindbis, evidence has been obtained for interactions be- as a cytosolic protein and is incorporated into virions
tween the cytoplasmic tail of the viral glycoproteins and almost immediately after synthesis (Hay and Skehel,
the nucleocapsids (Lopez et al., 1994), and for Semliki 1975). In the virion this protein is localized as an electron-
Forest virus, it has been shown that the coexpression of dense layer underneath the lipid bilayer. This position
the nucleocapsid and spike proteins are sufficient to allows M1 to interact with the membrane lipids and the
allow budding of the virus to occur (Suomalainen et al., cytoplasmic tails of the viral glycoproteins hemagglutinin
1992). However, other enveloped RNA viruses, such as and neuraminidase as well as with the viral ribonucleo-
Rhabdoviridae, Orthomyxoviridae, and Paramyxoviridae,
protein (RNP) and with the viral NS2 protein (Yasuda et
present a more complicated picture in terms of the inter-
al., 1993). Distinct domains of the M1 protein such as
actions that coordinate viral assembly, because they pos-
RNA binding sites (Ye et al., 1987, 1989) and membrane
sess a matrix protein localized inside the lipid bilayer. For
binding domains (Gregoriades, 1980) may allow the as-these viruses, the sequence of events and the molecular
sociation with vRNPs or membranes, respectively. There-mechanisms that govern viral assembly require further
fore, M1 might act as an adapter molecule and possiblyanalysis.
initiate the process of viral assembly. However, there areInfluenza viruses, members of the Orthomyxoviridae,
many questions about the molecular mechanisms thatare negative-stranded RNA viruses with an outer lipid
govern viral assembly that have yet to be answered. So
far, no evidence has been obtained for a direct interac-
tion between M1 and the viral glycoproteins hemaggluti-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (203) 785-7467. E-mail: jrose@biomed.med.yale.edu. nin and neuraminidase. The nature of the M1 protein
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interaction with lipid and protein components of mem- or into the EcoRI/HindIII sites of pBS(KS/) Bluescript,
respectively. To generate mutants of the matrix proteinbranes is also not clear (reviewed in Lamb, 1989).
gene, site-directed mutagenesis was performed usingMembrane interactions were examined in vivo for the
the Sculptur in vitro mutagenesis system (Amersham).matrix protein of the enveloped, negative-stranded RNA
This technique is based upon the method described byrhabdovirus vesicular stomatitis virus (VSV) (Chong and
Nakamaye and Eckstein (1986) in which the mutatedRose, 1993, 1994). These studies showed that a substan-
strand contains thionucleotides. This strand is protectedtial fraction of matrix protein was tightly associated with
against restriction cleavage with NciI and can be se-the plasma membrane and was chemically or conforma-
lected after exonuclease digestion. The following oligo-tionally different from soluble matrix protein. Based on
nucleotides were used to generate mutants 1–7 (Fig. 4):these findings the authors suggested a model for the
5*GATATTGAAAGATGAGTGGTGGAACCGAGGGCGAAA-assembly of VSV in which a fraction of newly synthesized
CGGGCGGTGGCTCTATCGTCCCGTC3* for mutant 1, thematrix protein remains soluble in the cytoplasm, where
oligonucleotide 5*CCTCTGACTAAGGGGGGTGGAGGA-it binds to and facilitates assembly of nucleocapsids.
GGTGGGGGCACGCTCACCGTGCCTAG for mutant 2, theAnother fraction of the matrix protein binds tightly to the
oligonucleotide 5*GCCAGTTGTATGGGCGGCGGAGG-cellular plasma membrane. Condensed nucleocapsids
CAACAGGATGGGGGCTG3* for mutant 3 and the oligo-would then bind to regions of the membrane containing
nucleotide 5*GGGCTGTGACCACTGAAGGGGGAGGT-the matrix protein.
GGCGGGGGATGCGCAACCTGTGAACAGA to generateIt is possible that the matrix protein M1 of influenza
mutant 4. For mutants 1 to 4, the underlined nucleotidesvirus functions in a manner similar to that proposed for
replaced the existing ones with glycine (see Fig. 4). Thethe matrix protein of VSV. We wanted to determine
oligonucleotide 5*GGATTTGTGTTCACGAAGACCGTG-whether the influenza A virus is an example of a second
CCTAG was used to generate mutant 5 and the oligonu-family of enveloped negative-stranded RNA viruses
cleotide 5*GGGGCCAAAGAAATAGCAAAGAGTTATTC-whose matrix protein is able to associate with host cell
TGCTGGTGCAAAGGCCAGTTGTATGGG to generatemembranes. Furthermore we wanted to characterize the
mutant 6. The underlined nucleotides in mutants 5 andnature of M1’s membrane binding, define potential mem-
6 replaced leucine residues with charged amino acidsbrane-binding domains by site-directed mutagenesis in
(Fig. 4). A 41 mer (5*CATTCCATGGGGCCAAAGAAGTA-vivo, and to determine if the viral glycoproteins influenced
TGCGCAACCTGTGAACAG) consisting of 20 nucleotidesbinding of M1 to membranes.
at the 3* (underlined) and 22 nucleotides at the 5* end
of the desired mutation was used to delete the sequenceMATERIALS AND METHODS
encoding amino acids 115–146 and was designated mu-
tant 7. The mutant genes were cloned into pBS(KS/)Viruses and antibodies
Bluescript where they can be expressed under control
Plaque-purified influenza WSN (H1N1) was used to of the T7 promoter. The presence of the mutations was
infect embryonated chicken eggs as described earlier verified by sequencing. In addition to the described mu-
(Doms et al., 1985). To purify virions from the allantoic tants, double mutants combining mutations with pre-
fluid, the virus was pelleted by centrifugation for 90 min viously designed mutants were constructed: mutant 1 /
at 35,000 rpm in a Beckman Ti45 rotor and resuspended 3, mutant 1 / 4, mutant 1 / 7, and mutant 5 / 6. This
in 10% sucrose. The virus was then passaged through has been achieved for mutants 1 / 3, 1 / 4, and 1 / 7
successively smaller needles from 18 to 26 G and loaded by ligating the mutated regions together. In this case, a
onto a discontinuous sucrose gradient of 30 and 60% KpnI–AflII fragment containing partial 5* sequences of
(wt/vol) sucrose in MNT (20 mM MES: 30 mM Tris, 100 mutant 1 was ligated into the KpnI–AflII sites of the plas-
mM NaCl, pH 7.5). The virus bands were collected, UV mids containing mutant 3, 4, and 7 genes, respectively.
inactivated, and used to immunize rabbits. The specificity Mutant 5 / 6 was constructed by using the two oligonu-
of the antibody obtained was confirmed by immunopreci- cleotides used to generate mutants 5 and 6 simultane-
pitating radioactively labeled MDCK cells infected with ously for the site-directed mutagenesis reaction. A plas-
influenza WSN virus. The recombinant vaccinia virus mid for engineering of a cell line expressing the wild-
vTF7-3 (Fuerst et al., 1986) was prepared as previously type matrix protein was constructed by cloning the gene
described (Whitt et al., 1989). into the XbaI site of the vector pCB6 (Hunziker et al.,
1991). The plasmid was designated pCB6-M1. The cod-
Plasmid constructions ing region in this construct was expressed from the CMV
promoter.
Plasmid DNAs encoding the matrix, hemagglutinin, or
Cellsneuraminidase proteins of influenza WSN (generously
provided by Dr. Peter Palese, Mount Sinai Hospital, New MDCK cells and HeLa cells were maintained in DMEM
supplemented with 7 or 5% fetal bovine serum, respec-York) were cloned into the XbaI site, HindIII/XbaI sites,
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tively. Monolayers of MDCK cells were transfected with 107) by the equilibrium sedimentation method described
above. The visible membrane band at the 10/65% su-pCB6-M1 via calcium–phosphate precipitation (Wigler et
al., 1979). G418 (0.5 mg/ml)-resistant colonies of cells crose interface was removed by side puncturing the cen-
trifuge tube. Membranes were diluted to 10 ml with 10were isolated and screened for expression of M1 protein
by immunofluorescence, immunoprecipitation, and West- mM Tris–HCl (pH 7.4) and pelleted by centrifugation at
35,000 rpm for 4 hr at 47 using a Beckman SW41 rotor.ern blot. The transformed cell line was designated
MDCK-M1. The membrane pellet was resuspended in 300 ml of 10
mM Tris–HCl (pH 7.4) and kept on ice.
Expression, radiolabeling, and immunoprecipitation of
proteins
RESULTS
HeLa cells (106 cells per 3.5-cm plate) were infected
M1 protein associates with cellular membranes in thewith vTF7-3 (Fuerst et al., 1986) at a multiplicity of infec-
absence of other influenza proteinstion of 10. After 30 min, the plasmids encoding wild-type
or mutant matrix proteins, hemagglutinin, or neuramini-
To obtain a high level of M1 protein expression in thedase were transfected using TransfectACE (Rose et al.,
absence of other influenza proteins, we used a transient1991) in 1 ml DMEM. Plasmid amounts were 5 mg for
expression system in which HeLa cells were first in-plasmids expressed individually or 1.5 mg of M1 and 3.5
fected with a recombinant vaccinia virus (vTF7-3) encod-mg of hemagglutinin or neuraminidase for coexpression
ing the bacteriophage T7 polymerase (Fuerst et al., 1986).experiments. After 3 hr, the cells were supplemented
Cells were then transfected with a plasmid encoding M1with 5% fetal bovine serum and incubated for an addi-
(influenza A, WSN) under the control of the T7 promoter.tional hour. Cells were then labeled for 1 hr with [35S]-
Four and one-half hours postinfection, cells were labeledmethionine, followed by a 1-hr chase. For labeling of
for 60 min with [35S]methionine, followed by a 1-hr chase.MDCK-M1 cells, the cells were induced 17 hr with 10
When cell lysates were immunoprecipitated with anti-mM sodium butyrate in complete culture media to upreg-
influenza serum and analyzed by SDS–PAGE, a 27-kDaulate M1 expression and labeled with [35S]methionine for
protein was detected. The expressed protein comigrated1 hr before further processing.
with M1 protein from solubilized wild-type influenza A
WSN virions (data not shown).Isopycnic gradient centrifugation and
To examine the distribution of M1 protein inimmunoprecipitation
transfected HeLa cells, the cell lysates were centrifuged
Transfected and metabolically labeled HeLa cells (2 on equilibrium density gradients (Bergmann and Fusco,1 106) or metabolically labeled MDCK-M1 cells (2 1 106) 1988). This method is used to determine the membrane
were harvested and fractionated essentially as described association of proteins. For this assay, total cell lysates
by Bergmann and Fusco (1988), with modifications. were prepared by disrupting cells with a Dounce homog-
Plates were first rinsed with PBS and then scraped into enizer. The postnuclear supernatants were adjusted to
an ice-cold 10% (wt/wt) sucrose homogenization buffer 80% sucrose, placed at the bottom of a centrifuge tube,
containing 10 mM Tris–hydrochloride (Tris–HCl, pH 7.4), and overlaid with sucrose in steps of decreasing density
1 mM EDTA, and 100 kallikrein units of aprotinin per (65 and 10%). Following centrifugation, membranes and
milliliter. Cells were disrupted with 25 strokes of a membrane-associated proteins band at the 10/65% inter-
Dounce homogenizer on ice. Nuclei and debris were face, whereas soluble proteins remain at the bottom of
removed from the cell lysate by centrifugation at 4000 the gradient.
rpm for 4 min at 47. The resulting supernatant was made When the M1 protein was expressed in HeLa cells and
to 80% (wt/vol) sucrose, placed at the bottom of a Beck- analyzed for membrane association by this fractionation
man SW41 centrifuge tube, and overlaid with 5 ml 65% scheme, the majority of M1 protein remained with cyto-
(wt/vol) and 2.5 ml 10% (wt/vol) sucrose. The step gradi- solic proteins at the bottom of the gradient, while 12 to
ent was then centrifuged to equilibrium at 35,000 rpm for 19% of M1 colocalized with membranes at the 10/65%
18 hr at 47. Fractions were collected from the top, diluted sucrose interface (Fig. 1A).
with detergent solution, and immunoprecipitated with In order to determine if M1 associates with mem-
rabbit anti-influenza serum as previously described branes in a time-dependent manner, a pulse-chase ex-
(Rose and Bergmann, 1983). Labeled proteins were ana- periment labeling M1 for 15 min with [35S]methionine or
lyzed by SDS–PAGE and fluorography. chasing for an additional 45 min was performed. The
amount of membrane-bound M1 was slightly but proba-
Preparation of cellular membranes
bly not significantly lower directly after the chase, indicat-
ing that membrane association occurs very rapidly (dataTotal cellular membranes were prepared from
transfected and metabolically labeled HeLa cells (1.5 1 not shown).
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M1 associates with membranes in the presence of
hemagglutinin and neuraminidase
It was then of interest to determine if the coexpression
of either hemagglutinin or neuraminidase with M1 would
alter the fraction of M1 associated with membranes. In
this case, separate plasmids encoding the hemagglutinin
or neuraminidase and M1 proteins were transfected to-
gether into HeLa cells. Coexpression was verified by
immunofluorescence microscopy at 6 hr posttransfection
(data not shown). The membrane association of cells
coexpressing M1 and hemagglutinin, or M1 and neur-
aminidase, was studied by subjecting the transfected
cell lysates to isopycnic gradient analysis. Samples were
fractionated and immunoprecipitated. After separation by
SDS–PAGE, the amount of M1 in the membrane fraction
and in the soluble fractions was determined by densitom-
etry (Figs. 1B and 1C). Again, approximately 15% of M1
was membrane-bound. Thus, coexpression of M1 with
hemagglutinin or neuraminidase did not alter the extent
of membrane association of M1 protein.
In the above experiments, the interaction of the M1
protein with membranes could have been an artifact of
vaccinia virus infection. To examine membrane associa-
tion of M1 in the absence of vaccinia virus, we used a
MDCK cell line expressing M1 constitutively. When M1
protein was metabolically labeled after induction with
sodium butyrate and its distribution was examined in this
cell line, 15% of M1 was found to be bound to membranes
(Fig. 2A). M1 was not expressed to visible levels in the
uninduced control (Fig. 2B). Thus, the membrane binding
of M1 was not specific to vaccinia-infected cells but was
a property of the matrix protein itself.
M1 protein interacts stably with cellular membranes
Although the M1 protein structure has not been deter-
mined, analysis of the primary amino acid sequence of
M1 does not reveal any stretches of hydrophobic resi-
dues sufficient to act as a transmembrane domain. Thus,
M1 might be expected to behave as a peripheral mem-
brane protein. In order to test if M1 is a peripheral protein,
FIG. 1. Analysis of membrane-associated matrix protein M1. HeLa membrane-bound M1 protein was subjected to treat-
cells were first infected with vTF7-3 and then transfected with plasmid ments which would characteristically remove peripheral
DNA encoding the M1, hemagglutinin, or neuraminidase protein. Four
membrane proteins, such as high pH, changes in ionicand one-half hours postinfection, the cells were pulse-labeled with
strength, or chelation of divalent cations.[35S]methionine for 60 min, chased for 1 hr, and then subsequently
homogenized with a Dounce homogenizer, brought to 80% sucrose, For these experiments, total cellular membranes con-
and overlaid with 65 and 10% sucrose layers. The step gradient was taining associated [35S]methionine-labeled M1 protein
centrifuged to equilibrium and then fractionated from the top of the from transfected HeLa cells were prepared by the su-
gradient. The fractions were immunoprecipitated with rabbit anti-influ-
crose flotation method. The visible membrane band atenza serum, analyzed by SDS– PAGE, and visualized by fluorography.
the 65/10% interface was removed by side puncture ofA shows a gradient from cells expressing influenza M1 protein individu-
ally. B shows a gradient from cells coexpressing hemagglutinin and the centrifuge tube, dialyzed, pelleted, and then treated
M1 proteins. C shows a gradient from cells coexpressing neuramini- with 2 M KCl, 50 mM EDTA, or carbonate buffer (pH
dase and M1 proteins. Fractions are numbered from the top to the 11). High-salt extraction (2 M KCl) is expected to shield
bottom. Vaccinia virus (v.v.) background proteins are indicated. Quanti-
charges and weaken ionic interactions which bind pe-tation of the amount of labeled protein in each fraction was carried out
ripheral proteins to membranes either directly or indi-by scanning densitometry of autoradiographs.
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workers suggested that the lipid binding domain is lo-
cated exclusively within the 80 amino acids of the amino
terminus. However, both suggestions were based on in
vitro studies of cyanogen bromide (Gregoriades and
Frangione, 1981) or formic acid and V8 protease (Ye et
al., 1987) fragments of M1 that interacted with liposomes.
Because discrepancies exist in the reported location of
the lipid binding domains, based on in vitro binding of
protein fragments, we wanted to examine the lipid bind-
ing domains in vivo. To examine these domains, we ini-
tially changed the hydrophobicity of the amino acids in
the two areas of M1 suggested by Gregoriades and Fran-
gione (1981). If these regions are indeed responsible
for lipid binding, then membrane association would be
expected to decrease or disappear with the mutant pro-
teins.
The hydrophobicity of these regions was altered by
substituting the underlined hydrophobic amino acids
with glycines (Fig. 4, mutants 2 and 3). Another set of
mutants was created by substituting neutral amino acids
FIG. 2. Distribution of M1 in MDCK cells expressing M1 constitutively. (Leu 66, Leu 117, Leu 124) with charged amino acids
To examine the distribution of M1 in MDCK-M1 cells, M1 expression (Lys) (Fig. 4, mutants 5 and 6). Furthermore, a mutant
was induced for 17 hr with sodium butyrate. The cells were then labeled
was created by deleting amino acids 115–146 (Fig. 4,with [35S]methionine for 1 hr and subjected to isopycnic gradient analy-
mutant 7). The mutated M1 constructs were transientlysis. After fractionation and immunoprecipitation with a polyclonal anti-
influenza serum, samples were separated by SDS–PAGE and visual- expressed in HeLa cells. The binding of the mutant pro-
ized by fluorography. A shows an influenza virus from cells expressing teins to the plasma membrane was examined by immu-
M1 after induction with sodium butyrate; B, without induction with so- nofluorescence. Although this is not a quantitative
dium butyrate. In this case, M1 is not expressed to visible levels. The
method, the binding of the mutants was indistinguishablebands above M1 represent background MDCK bands.
from wild-type M1 (data not shown). When the mem-
rectly through other membrane proteins. Membrane as-
sociation mediated by divalent cation bridge formation
can be disrupted by the addition of EDTA. Vesicles can
also be transformed into membrane sheets when treated
with carbonate buffer, which consequently should re-
lease soluble or peripheral proteins trapped in vesicles
(Fujiki et al., 1982). To determine whether any of these
conditions disrupted M1 association with membranes,
the samples were subjected to sucrose flotation analysis.
None of these conditions released M1 from the mem-
brane fraction (Fig. 3). Thus, although the M1 protein has
no transmembrane domain in its primary sequence, the
fraction of M1 bound to membranes behaves as an inte-
gral protein.
FIG. 3. Stability of influenza M1 protein association with membranes.Site-directed mutagenesis of functional domains of
Total cellular membranes containing associated M1 protein from
the matrix protein transfected and [35S]methionine-labeled HeLa cells were prepared by
equilibrium density gradients. Membranes were extracted with carbon-
Studies from other groups have demonstrated the in- ate buffer (pH 11) for 30 min at 07 or treated with 2 M KCl, 10 mM
EDTA, 10 mM Tris–HCl (pH 7.4), or with 50 mM EDTA, Tris–HCl (pHteraction of M1 with lipids by reconstituting lipid and
7.4) for 1 hr at 257. Control membranes were left untreated. Samplespurified M1 protein (Bucher et al., 1980; Gregoriades,
were brought to 80% sucrose, and membranes were reisolated in a1980; Gregoriades and Frangione, 1981; Ye et al., 1987).
second round of isopycnic gradient analysis. Fractions were collected,
Gregoriades and Frangione assigned the lipid binding diluted with detergent solution, immunoprecipitated with a polyclonal
site to two regions of the M1 protein (amino acids 62 – serum raised against influenza virions, and analyzed by SDS–PAGE.
Fractions are numbered from the top to the bottom.68 and 114–133). In contrast to this finding, Ye and co-
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brane-binding capacity of these proteins was examined
by isopycnic gradient analysis, all of the mutants still
showed membrane binding to the same level as wild-
type M1. Two of them are shown as an example (Figs.
5B and 5C).
Reexamination of the hydrophobicity plots (Fig. 4) re-
vealed two additional regions which might be responsi-
ble for the membrane binding (amino acids 3–12 and
142–147). Therefore, additional M1 mutant proteins were
constructed with substitutions in these two new potential
lipid-binding domains (Fig. 4, mutants 1 and 4). These
mutants also showed the wild-type level of membrane
binding (Figs. 5A and 5D). Furthermore, double mutants
were constructed combining mutations in these two new
potential lipid-binding domains with previously designed
mutants: mutants 1 / 3, 1 / 4, 1 / 7, and 5 / 6. All
these mutants were transiently expressed in HeLa cells
and showed a distribution pattern by immunofluores-
cence similar to that of the wild-type M1 protein. The
mutants were subsequently analyzed by sucrose flotation
analysis to examine membrane binding. The results
showed that all mutants exhibited the same level of mem-
brane association as that observed with the wild-type
matrix protein (data not shown).
Mutant matrix proteins interact stably with
membranes
Although these mutants still associated with cellular
membranes, the stability of the membrane binding might
be altered. Therefore, HeLa cell membranes containing
the mutated proteins were prepared and subjected to
high-salt or high-pH treatments. The results for those
mutants examined (mutants 1–7) revealed that M1 was
still bound tightly to membranes. As an example, the
results for two mutants are shown (Fig. 6).
DISCUSSION
We show here that approximately 15% of the matrix
protein M1 of influenza virus WSN binds to cellular mem-
branes in vivo when expressed in the absence or pres-
ence of the viral glycoproteins. This fraction of mem-
brane-bound matrix protein was also observed in MDCK
cells expressing the matrix protein constitutively. There-
fore, the ability of a substantial fraction of M1 protein to
bind tightly to membranes is a special feature of the
FIG. 4. Hydrophobicity of M1 proteins with mutations in potential
lipid binding domains. Mutants of the M1 protein were constructed by
substituting the underlined amino acids with glycine (mutants 1–4),
replacing leucine residues with charged amino acids (mutants 5 and
6), or deleting hydrophobic regions C and D (mutant 7). The blackened
areas in the hydrophobicity plots represent the hydrophobicity associ-
ated with amino acids that were removed or replaced. Hydrophobicity
of wild-type M1 protein is shown as well.
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FIG. 5. Analysis of membrane-associated mutant matrix protein M1. Mutant M1 proteins were transiently expressed in HeLa cells, metabolically
labeled with [35S]methionine, and subjected to sucrose flotation analysis. Fractions were diluted with detergent solution, immunoprecipitated with
rabbit anti-influenza serum, and analyzed by SDS–PAGE. A through D show gradients from cells expressing mutant M1 proteins 1, 2, 3, or 4,
respectively. Fractions are numbered from the top to the bottom. Quantitation of the amount of labeled protein in each fraction was carried out by
scanning densitometry of autoradiographs.
matrix protein M1. Others have already reported M pro- protein (Chong and Rose, 1993; Stricker et al., 1994).
However, Sanderson et al. (1993) reported that Sendaitein binding to artificial phospholipid vesicles (Bucher et
al., 1980; Gregoriades and Frangione, 1981). virus M protein associates with membranes only in the
presence of the viral glycoprotein. The reason for thisAlthough a previous study involving analysis of influ-
enza-infected cells suggested that M1 proteins could as- discrepancy is unclear.
We also found that the membrane-bound fraction ofsociate with cellular membranes (Hay, 1974), the ques-
tion of a requirement for the viral glycoproteins hemag- M1 shows the characteristics of an integral membrane
protein rather than those of a peripheral protein. Thereglutinin and neuraminidase remained open. It has been
suggested that once M1 and HA and/or NA proteins are is no evidence that M1 is covalently modified with lipids,
which might explain its strong membrane binding. Thelocalized to the plasma membrane in infected cells, a
subsequent M1–HA/NA interaction may induce the clus- stable membrane association demonstrated here sug-
gests that part of M1 may extend into the lipid bilayer,tering of HA and NA proteins and specific host cell glyco-
proteins into areas active in virus assembly (Choppin rendering it resistant to conditions that characteristically
remove peripherally associated membrane proteins. Aet al., 1972). Although this seems plausible, we did not
observe enhancement of M1 protein binding to mem- membrane-penetrating, cross-linking reagent has la-
beled M1 proteins in intact virions (Gregoriades andbranes containing HA or NA proteins although the inter-
actions could be weak and unstable to gradient sedimen- Frangione, 1981), and there is evidence obtained from
in vitro studies of cyanogen bromide and formic acidtation. A further possibility might be that M1 needs to
be assembled with a nucleocapsid complex in order to fragments that the M1 protein is at least partly embedded
in the viral envelope, probably like VSV matrix proteinassociate with the cytoplasmic domain of the glycopro-
teins. However, recent reports that influenza virus parti- as an amphipathic helix (Lenard and Vanderoef, 1990;
Mancarella and Lenard, 1981; Wiener et al., 1985). Suchcles containing HA or NA without their cytoplasmic tail
could be obtained (Jin et al., 1994; Garcia-Sastre and proteins are believed to introduce strain into the other-
wise fluid lipid bilayer and induce lateral curvature, whichPalese, 1995) suggested that the interactions of M1 with
the cytoplasmic tails may be dispensable for virus as- can promote protein–protein interactions as well as
cause membrane rigidity (Gennis, 1989).sembly. Interestingly, the matrix proteins of a second
family of enveloped RNA viruses, the rhabdovirus VSV, The other studies described here were designed to
identify membrane binding domains in M1 protein. Identi-and of Sendai virus, a member of a third family, the para-
myxoviruses, have also been shown not to increase fication of these domains might provide a clearer under-
standing of the mechanism by which matrix proteins inmembrane binding after coexpression of the viral glyco-
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demonstrated membrane binding. Since mutant M1 pro-
teins still bound stably to cellular membranes, the ques-
tion of the mechanism of binding still remains.
A possible explanation for our results is that mem-
brane association does not involve the hydrophobic do-
mains targeted for analysis. Other, amphipathic regions
of M1 may fold in such a way that they bind tightly to
membranes. Alternatively, the membrane interaction
could involve several of the hydrophobic domains, and
the remaining domains even in the double mutants might
be sufficient for binding. It is clearly difficult to carry
out meaningful mutagenesis studies in the absence of a
three-dimensional structure of M1 protein. The availabil-
ity of a structure of M1 will likely be required to guide
any future studies.
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